M. Lemoine, S. Eholié, and K. Lacombe, Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach, J Hepatol, vol.62, pp.469-76, 2015.

D. Razavi-shearer, I. Gamkrelidze, and M. H. Nguyen, Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study, Lancet Gastroenterol Hepatol, vol.3, pp.383-403, 2018.

A. Schweitzer, J. Horn, and R. T. Mikolajczyk, Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between, Lancet, vol.386, pp.1546-55, 1965.

A. S. Lok, Chronic hepatitis B, N Engl J Med, vol.346, pp.1682-1685, 2002.
URL : https://hal.archives-ouvertes.fr/hal-02507275

E. Keane, A. L. Funk, and Y. Shimakawa, Systematic review with metaanalysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa, Aliment Pharmacol Ther, vol.44, pp.1005-1022, 2016.

C. Chakvetadze, C. Roussin, and J. Roux, Efficacy of hepatitis B serovaccination in newborns of African HBsAg positive mothers, Vaccine, vol.29, pp.2846-2855, 2011.

N. Hannachi, O. Bahri, and S. Mhalla, Hépatite virale B chez les femmes enceintes tunisiennes : facteurs de risque et intérêt de l'étude de la réplication virale en cas d'antigène HBe négatif, Pathol Biol, vol.57, pp.43-50, 2009.

W. Szmuness, Recent advances in the study of the epidemiology of hepatitis B, Am J Pathol, vol.81, pp.629-50, 1975.

D. M. Parkin, The global health burden of infection-associated cancers in the year 2002, Int J Cancer, vol.118, pp.3030-3074, 2006.

P. Hainaut and P. Boyle, Curbing the liver cancer epidemic in Africa, Lancet, vol.371, pp.367-375, 2008.

, Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection, 2015.

, Investing in the fight against hepatitis B and C in Senegal: National Strategic Plan, 2013.

, European Association For The Study Of The Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection, J Hepatol, vol.57, pp.167-85, 2012.

H. Patton and T. T. Tran, Management of hepatitis B during pregnancy, Nat Rev Gastroenterol Hepatol, vol.11, pp.402-411, 2014.

I. Gentile, E. Zappulo, and A. R. Buonomo, Prevention of mother-tochild transmission of hepatitis B virus and hepatitis C virus, Expert Rev Anti Infect Ther, vol.12, pp.775-82, 2014.

F. Chabrol, N. Noah, D. Tchoumi, and E. P. , Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs, BMJ Open, vol.9, p.25415, 2019.

M. Lemoine and M. R. Thursz, Battlefield against hepatitis B infection and HCC in Africa, J Hepatol, vol.66, pp.645-54, 2017.

G. Abedi, F. Rostami, and A. Nadi, Analyzing the dimensions of the quality of life in hepatitis B patientsusing confirmatory factor analysis, Glob J Health Sci, vol.7, p.46854, 2015.

A. R. Levy, K. V. Kowdley, and U. Iloeje, The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons, Value Health, vol.11, pp.527-565, 2008.

Z. M. Younossi, G. Guyatt, and M. Kiwi, Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease, Gut, vol.45, pp.295-300, 1999.

S. J. Schwarzenberg, S. C. Ling, and Y. K. Cloonan, Health-related quality of life in pediatric patients with chronic hepatitis B living in the United States and Canada, J Pediatr Gastroenterol Nutr, vol.64, pp.760-769, 2017.

J. Lu, A. Xu, and J. Wang, Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China. BMC Health Serv Res, vol.13, p.37, 2013.

Z. Karacaer, B. Cakir, and H. Erdem, Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey. Health Qual Life Outcomes, vol.14, p.153, 2016.

S. J. Kim, K. T. Han, and S. Y. Lee, Quality of life correlation with socioeconomic status in Korean hepatitis-B patients: a cross sectional study, Health Qual Life Outcomes, vol.13, p.55, 2015.

G. Woo, G. Tomlinson, and C. Yim, Health state utilities and quality of life in patients with hepatitis B, Can J Gastroenterol, vol.26, pp.445-51, 2012.

G. Zhuang, M. Zhang, and Y. Liu, Significant impairment of healthrelated quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls, Health Qual Life Outcomes, vol.12, p.101, 2014.

N. Ul-haq, M. A. Hassali, and A. A. Shafie, A cross sectional assessment of health related quality of life among patients with Hepatitis-B in Pakistan, Health Qual Life Outcomes, vol.10, p.91, 2012.

E. T. Lam, C. L. Lam, and C. L. Lai, Health-related quality of life of Southern Chinese with chronic hepatitis B infection, Health Qual Life Outcomes, vol.7, p.52, 2009.

J. Chao, L. Song, and H. Zhang, Effects of comprehensive intervention on health-related quality of life in patients with chronic hepatitis B in China, BMC Health Serv Res, vol.13, p.386, 2013.

E. Ochola, P. Ocama, and C. G. Orach, High burden of hepatitis B infection in Northern Uganda: results of a population-based survey, BMC Public Health, vol.13, p.727, 2013.

A. Rajendra and J. B. Wong, Economics of chronic hepatitis B and hepatitis C, J Hepatol, vol.47, pp.608-625, 2007.

M. Toy, Cost-effectiveness of viral hepatitis B & C treatment, Best Pract Res Clin Gastroenterol, vol.27, pp.973-85, 2013.

Y. Y. Lui, K. K. Tsoi, and V. W. Wong, Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy, Antivir Ther, vol.15, pp.145-55, 2010.

H. Dakin, M. Sherman, and S. Fung, Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective, Pharmacoeconomics, vol.29, pp.1075-91, 2011.

F. Hulstaert, C. Schwierz, and F. Nevens, Should chronic hepatitis B be treated as early as possible?, Int J Technol Assess Health Care, vol.29, pp.35-41, 2013.

J. Y. Park, J. Heo, and T. J. Lee, A novel estimation of the relative economic value in terms of different chronic hepatitis B treatment options, PLoS One, vol.8, p.57900, 2013.

D. E. Spackman and D. L. Veenstra, A cost-effectiveness analysis of currently approved treatments for HBeAg-positive chronic hepatitis B, Pharmacoeconomics, vol.26, pp.937-986, 2008.

A. Suijkerbuijk, A. J. Van-hoek, and J. Koopsen, Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country, PLoS One, vol.13, p.207037, 2018.

S. Nayagam, L. Conteh, and E. Sicuri, Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis, Lancet Glob Health, vol.4, pp.568-78, 2016.

H. F. Hung and T. H. Chen, Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence, Vaccine, vol.27, pp.6770-6776, 2009.

C. Klingler, A. I. Thoumi, and V. S. Mrithinjayam, Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique, Vaccine, vol.31, pp.252-261, 2012.

S. Y. Kim, J. A. Salomon, and S. J. Goldie, Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves, Bull World Health Organ, vol.85, pp.833-875, 2007.

M. De and L. Santé, de la prévention et de l'hygiène publique du Sénégal. Plan stratégique de lutte contre les hépatites virales au Sénégal, pp.2009-2013

A. Sall-diallo, M. Sarr, and Y. Fall,

, Dakar Méd, vol.49, pp.136-178, 2004.

A. A. Ndiaye, I. S. Fall, and G. Lo, HBsAg seroprevalence among Senegalese militaries, Mil Med Res, vol.2, p.5, 2015.

H. Diop-ndiaye, C. Touré-kane, and J. F. Etard, Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study), J Med Virol, vol.80, pp.1332-1338, 2008.

G. Lô, P. S. Diawara, and N. N. Diouf, Prévalence de l'antigène de surface du virus de l'hépatite B (AgHBs) chez les femmes enceintes au laboratoire de l'hôpital Militaire de Ouakam (HMO), Médecine Afr Noire, vol.2012, pp.241-245

G. Lô, N. N. Diouf, S. Sall, and A. , Prévalence de l'antigène de surface du virus de l'hépatite B au laboratoire de l'hôpital militaire de Ouakam entre, Médecine Afr Noire, pp.87-93, 2006.

S. Diop, Hépatites et Sécurité transfusionnelle au Sénégal. atelier AmBASS du 19 mai, 2015.

J. J. Ott, J. Horn, and G. Krause, Time trends of chronic HBV infection over prior decades -A global analysis, J Hepatol, vol.66, pp.48-54, 2017.

M. Vray, J. M. Debonne, and J. M. Sire, Molecular epidemiology of hepatitis B virus in Dakar, Sénégal, J Med Virol, vol.78, pp.329-363, 2006.

P. Roingeard, A. Diouf, and J. L. Sankale, Perinatal transmission of hepatitis B virus in Senegal, west Africa, Viral Immunol, vol.6, pp.65-73, 1993.

A. Jaquet, G. Wandeler, and J. Tine, Prevention and care of hepatitis B in senegal; awareness and attitudes of medical practitioners, Am J Trop Med Hyg, vol.97, pp.389-95, 2017.

V. Delaunay, L. Douillot, and A. Diallo, Profile: the niakhar health and demographic surveillance system, Int J Epidemiol, vol.42, pp.1002-1013, 2013.

, Station de Niakhar / Sites principaux / L'IRD au Sénégal / Sénégal / IRD -Sites de représentation / IRD -Sénégal

L. Kish, . Survey, and . Sampling, , 1968.

, Guidelines on hepatitis B and C testing, 2017.

S. Mohamed, A. Raimondo, and G. Pénaranda, Dried blood spot sampling for hepatitis B virus serology and molecular testing, PLoS One, vol.8, p.61077, 2013.

J. J. Heckman, The common structure of statistical models of truncation, sample selection and limited dependent variables and a simple estimator for such models, Ann Econ Soc Meas, vol.5, pp.475-92, 1976.

C. Q. Pan, Z. Duan, and E. Dai, Tenofovir to prevent hepatitis B transmission in mothers with high viral load, N Engl J Med, vol.374, pp.2324-2358, 2016.

J. Ware, M. Kosinski, and S. D. Keller, A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity, Med Care, vol.34, pp.220-253, 1996.